Protagonist Therapeutics Insider Sold Shares Worth $18,240,568, According to a Recent SEC Filing

03:23 AM EDT, 09/11/2026 (MT Newswires) -- Dinesh V Patel, Director, President and Chief Executive Officer, on September 08, 2026, sold 125,000 shares in Protagonist Therapeutics (PTGX) for $18,240,568. Following the Form 4 filing with the SEC, Patel has control over a total of 522,968 common shares of the company, with 522,968 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465926106831/xslF345X05/tm2625158-1_4seq1.xml